Form 3 Filing for LakeShore Biopharma Co., Ltd.

This filing is an initial statement of beneficial ownership of securities filed by Xue Linnan, a director at LakeShore Biopharma Co., Ltd. The filing, dated March 18, 2026, indicates that the reporting owner has no securities owned. The reporting owner's address is in Beijing, China. Linnan Xue signed the document on April 1, 2026.